Next Breath will sponsor and host the annual fall symposium of the American Association of Pharmaceutical Scientists? Inhalation and Nasal Technology Focus Group (INTFG) on September. 9th, 2011. The theme for this year?s symposium is ?Delivery of Biologics through the Lung: Challenges and Opportunities? with four speakers addressing the theme topic.
The one-day symposium will feature a poster session open to all areas of inhalation and nasal research. In addition, a ?Posters on the Podium? session will highlight selected posters and provide authors an opportunity to summarize their research.
?As one of the leading companies in the area of nasal and pulmonary delivery of drug products, Next Breath is excited to support this group of accomplished scientists in their mission to promote and advance the science of pharmaceutical inhalation and nasal drug delivery systems," Julie Suman, President of Next Breath.
The registration for the symposium is $ 100 for members, $ 150 non-member, and students attend for free.
It will be held at Next Breath?s facilities and includes lunch. Registration deadline is September 2nd, 2011.
Online registration at:
http://www.aaps.org/Meetings_and_Professional_Development/Conference_Mini_Sites/AAPS_Workshop_INTFG/AAPS_Workshop_INTFG/
About Next Breath
Next Breath is a cGMP contract services organization for pharmaceutical, biotech and medical device companies that bring inhalation and nasal products to market. Next Breath provides comprehensive solutions to the Oral, Inhaled, and Nasal Drug Products product development process. Our in vitro services range from pre-clinical formulation development to analytical testing in support of submissions to regulatory agencies. Next Breath has led successful submissions for pulmonary and nasal drug products in US and international markets. For more information please: 352-642-2141 or visit http://www.nextbreath.net.
About INTFG
The Inhalation and Nasal Technology Focus Group is a subgroup of the American Association of Pharmaceutical Scientists. The group?s objectives are to:
????Foster and advance the art and science of the pharmaceutical inhalation aerosol and nasal drug delivery system among focus group members and interested parties
????Provide and disseminate to its members information relating to matters of scientific and technical interest in the field of inhalation aerosol and nasal drug delivery products, aerosol and nasal technology, and related processes
????Encourage and undertake projects relating to matters of scientific and technical interest in the field of inhalation aerosol and nasal drug delivery products, aerosol and nasal technology, and related processes and, when appropriate, publish such findings in the pharmaceutical press
????Support lateral discussion and exchange of ideas across different specialties in the areas of novel drug delivery methods, delivery formulations, clinical trial issues and regulatory sciences specific to inhalation and nasal drug delivery
????Foster and encourage a spirit of friendly cooperation among its members and to promote favorable relations between its members and related health professionals
????Collect and disseminate, for the benefit of members and interested parties, such information as may be deemed of value
????Organize seminars and/or symposiums in the general area of inhalation aerosol and nasal drug products, aerosol and nasal drug delivery technology, and regulations for inhalation and nasal drug products
# # #
Related Aerosoles Press Releases
No comments:
Post a Comment